Clinical Trials Logo
  1. Home
  2. Diabetes Mellitus, Type 2
  3. NCT04592055
  4. Details
NCT04592055 Clinical Trial

The Effect of COVID-19 on Diabetes Mellitus

Diabetes Mellitus Clinical Trial

— COVID-19-DM  

Official title:
The Effect of COVID-19 on the Glycemic Control in Patients With Diabetes Mellitus

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04592055
Other study ID # UU-DM002
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 20, 2020
Est. completion date July 1, 2021

Study information
Verified date May 2021
Source Usak University
Contact Cevdet Duran
Phone 02762212121
Email drcduran@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study aimed to evaluate the effect of SARS-COV-2 infection on metabolic status in patients with diabetes mellitus. Patients' HbA1c levels before and after SARS-COV-2 infection will be evaluated.

Description:

In this time pediods, all patients with RT-PCR positive for SARS-COV-2 will be analysed for the presence of diabetes mellitus. Previous HbA1c levels will be obtained from hospital records. In these patients, previous A1c levels and A1c levels 3 months after the SARS-COV-2 infection will be compared.

Recruitment information / eligibility
Status Recruiting
Enrollment 500
Est. completion date July 1, 2021
Est. primary completion date October 15, 2020
Accepts healthy volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - All hospitalised diabetic patients with RT-PCR- positive for SARS-COV-2 will be enrolled. Exclusion Criteria: - The absence of diabetes mellitus RT-PCR- negative for SARS-COV-2 Non-hospitalised patients

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Turkey Usak University Training and Research Hospital Usak

Sponsors (1)
Lead Sponsor Collaborator
Usak University

Country where clinical trial is conducted

Turkey, 

Outcome
Type Measure Description Time frame Safety issue
Primary A1c the change in A1c levels 6 months (3 months before and after COVID-19
See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A